Compugen Ltd. (NASDAQ: CGEN) started the day on May 19, 2021, with a price decrease of -2.92% at $7.97. During the day, the stock rose to $8.18 and sunk to $7.82 before settling in for the price of $8.21 at the close. Taking a more long-term approach, CGEN posted a 52-week range of $6.74-$19.90.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -26.40%. Meanwhile, its Annual Earning per share during the time was 1.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 13.10%. This publicly-traded company’s shares outstanding now amounts to $83.68 million, simultaneously with a float of $82.41 million. The organization now has a market capitalization sitting at $617.67 million. At the time of writing, stock’s 50-day Moving Average stood at $8.41, while the 200-day Moving Average is $12.69.
Let’s gauge the efficiency of the firm, which has a total of 68 employees. It has generated 29,412 per worker during the last fiscal year. Meanwhile, its income per employee was -436,735. The stock had 1.59 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks gross margin was +61.25, operating margin was -1574.80 and Pretax Margin of -1484.90.
Compugen Ltd. (CGEN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Compugen Ltd.’s current insider ownership accounts for 12.00%, in contrast to 47.70% institutional ownership.
Compugen Ltd. (CGEN) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2021, the organization reported -$0.12 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.13) by $0.01. This company achieved a net margin of -1484.90 while generating a return on equity of -37.57. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
Compugen Ltd.’s EPS increase for this current 12-month fiscal period is 13.10% and is forecasted to reach -0.66 in the upcoming year.
Compugen Ltd. (NASDAQ: CGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Compugen Ltd. (CGEN). It’s Quick Ratio in the last reported quarter now stands at 10.60. The Stock has managed to achieve an average true range (ATR) of 0.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 308.84.
In the same vein, CGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.37, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.66 at the market close of one year from today.
Technical Analysis of Compugen Ltd. (CGEN)
If we take a close look at the recent performances of Compugen Ltd. (NASDAQ: CGEN), its last 5-days Average volume was 1.46 million that shows progress from its year to date volume of 1.31 million. During the previous 9 days, stock’s Stochastic %D was recorded 80.78% While, its Average True Range was 0.57.
Raw Stochastic average of Compugen Ltd. (CGEN) in the period of the previous 100 days is set at 15.93%, which indicates a major fall in contrast to 58.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 68.27% that was lower than 73.01% volatility it exhibited in the past 100-days period.